UBS O'Connor’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Sell |
210,205
-48,158
| -19% | -$447K | 0.1% | 148 |
|
|
2025
Q1 | $1.89M | Sell |
258,363
-12,059
| -4% | -$88.4K | 0.06% | 120 |
|
|
2024
Q4 | $2.31M | Buy |
270,422
+48,763
| +22% | +$416K | 0.06% | 139 |
|
|
2024
Q3 | $1.93M | Sell |
221,659
-17,000
| -7% | -$148K | 0.05% | 175 |
|
|
2024
Q2 | $1.63M | Buy |
238,659
+50,081
| +27% | +$343K | 0.05% | 225 |
|
|
2024
Q1 | $1.72M | Sell |
188,578
-143,513
| -43% | -$1.31M | 0.05% | 204 |
|
|
2023
Q4 | $1.48M | Sell |
332,091
-10,020
| -3% | -$44.7K | 0.05% | 216 |
|
|
2023
Q3 | $1.07M | Buy |
342,111
+40,000
| +13% | +$126K | 0.02% | 320 |
|
|
2023
Q2 | $1.56M | Sell |
302,111
-61,175
| -17% | -$316K | 0.03% | 329 |
|
|
2023
Q1 | $1.91M | Buy |
+363,286
| New | +$1.91M | 0.05% | 322 |
|
|
2022
Q4 | – | Sell |
-223,066
| Closed | -$926K | – | 217 |
|
|
2022
Q3 | $926K | Sell |
223,066
-289,820
| -57% | -$1.2M | 0.01% | 746 |
|
|
2022
Q2 | $2.06M | Buy |
+512,886
| New | +$2.06M | 0.02% | 639 |
|